Results 81 to 90 of about 1,118 (157)

Cost-Effectiveness of the Use of the Coronary Calcium Score in Primary Prevention as a Guide for the Therapeutic Decision. [PDF]

Arq Bras Cardiol, 2023
Nascimento CRD, Santos JM, Mendes R, Lopes JM, Tenório PP.   +4 more
europepmc   +1 more source

Farmacovigilancia de las estatinas

[EN] Statins are medications used to reduce high cholesterol levels by inhibiting its production in the liver and lowering levels of low-density lipoprotein cholesterol (LDL-C) in the blood. These medications work specifically by inhibiting the enzyme hydroxy-3-methyl-glutaryl coenzyme A reductase (HMGCR) in the liver, which is responsible for ...
openaire   +1 more source

Effect of lifestyle modification and atorvastatin on dyslipidemia and endothelial dysfunction markers in children with steroid resistant nephrotic syndrome. [PDF]

J Bras Nefrol
Kakkar V, Saha A, Agrawal P, Sharma S, Nagia A, Singh P, Pemde HK.   +6 more
europepmc   +1 more source

Coronary Artery Disease and Chronic Kidney Disease: A Tale of Two Organs. [PDF]

Arq Bras Cardiol
Kranjec I.
europepmc   +1 more source

Estatinas e fitoterapia em dislipidémias

, 2011
Introduction: Cardiovascular Diseases (CD) have a great impact on mortality and morbidity worldwide. Being one of the major risk factors for the emergence or worsening of CD, it is important to prevent or to implement an effective and safe pharmacotherapy in the treatment of dyslipidaemia.
openaire   +1 more source

Screening for Lysosomal Acid Lipase Deficiency in a Lipid Clinic. [PDF]

Arq Bras Cardiol
Brasil Z, Fonseca FAH, Curiati MA, Kyosen SO, Pereira VG, Fonzar WT, Pesquero JB, Patrício FRDS, Yamamoto MH, Yamamoto JU, D'Almeida V, Martins AM, Izar MC.   +12 more
europepmc   +1 more source

Enfermedad de Steinert y estatinas

Atención Primaria, 2003
Pujol Olivares, X., Vilamú Talavera, M., Esquerrà Alibés, M.T., Deniel Rosanas, J.   +3 more
openaire   +1 more source

[Pharmacological adherence and cardiometabolic goals in successfully reperfused acute myocardial infarction]. [PDF]

Rev Med Inst Mex Seguro Soc
Fabela-Hardy CA, Moreno-Ruiz LA, Necoechea-Osuna Y, Romero-Zertuche D, Almeida-Gutiérrez E, Lupercio-Mora K, Santos-Martínez LE.   +6 more
europepmc   +1 more source

Betabloqueadores en pacientes posinfarto de miocardio. [PDF]

Arch Peru Cardiol Cir Cardiovasc
Britto FW.
europepmc   +1 more source

Medicina personalizada no tratamento com estatinas

, 2019
Uma das principais causas de morte a nível mundial é a doença cardiovascular sendo as dislipidemias um fator de risco importante para esta situação patológica. As Estatinas são um dos principais grupos de fármacos utilizados para o tratamento de dislipidemias.
openaire   +1 more source